Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Leslie Chong"'
Autor:
Yuman Fong, Amanda Seiz, Hirva Mamdani, Melissa Polasek, Daneng Li, Leslie Chong, Alexander I Spira, Jennifer Leddon, Seymour Fein, Nick Ede, Ursula McCurry, Sharon Yavrom, Giovanni Selvaggi
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/8d18a0d35fb643a68cee3c39228afbff
Autor:
Leslie A. Sechel Vela, Claudia Álvarez, Ninfa Aquino, Silvia Argueta, Ma. del Carmen Chacón, Carlota Chiché, Jacqueline Malin, Leslie Chong, Dulce Mazariegos, Olga Ruíz, Julia Salazar, Sofía Salazar
Publikováno v:
Revista Psicólogos. 6
La presente investigación tuvo como objetivo conocer el nivel de ansiedad que provoca la transición de nivel primario al nivel básico en adolescentes entre 10y 14 años de edad. Se tomó una muestra de siete sujetos varones de distintos centros ed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::67bd3d81c802fc0c8070098609514d72
https://doi.org/10.59205/rp.v6i19.135
https://doi.org/10.59205/rp.v6i19.135
Autor:
Anthony J. Good, Mark T. Marino, Nicholas J. Ede, Leslie Chong, Christoph C. Zielinski, Joshua Tobias, Mirjana Drinic, Teerapat Ungtrakul, Wen-Chi Chou, Li-Yuan Bai, Aumkhae Sookprasert, Jedzada Maneechavakajorn, Suebpong Tanasanvimon, Thomas Cheung Yau, Chia-Jui Yen, Chaiyut Charoentum, Wichit Arpornwirat, Arunee Dechaphunkul, Iurie Bulat, Marina Maglakelidze, Yee Chao, Erika Garner-Spitzer, Ursula Wiedermann
Supplementary Data 3 & 4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aaf4da22beef67401032aee58a6e5653
https://doi.org/10.1158/1078-0432.22480941
https://doi.org/10.1158/1078-0432.22480941
Autor:
Anthony J. Good, Mark T. Marino, Nicholas J. Ede, Leslie Chong, Christoph C. Zielinski, Joshua Tobias, Mirjana Drinic, Teerapat Ungtrakul, Wen-Chi Chou, Li-Yuan Bai, Aumkhae Sookprasert, Jedzada Maneechavakajorn, Suebpong Tanasanvimon, Thomas Cheung Yau, Chia-Jui Yen, Chaiyut Charoentum, Wichit Arpornwirat, Arunee Dechaphunkul, Iurie Bulat, Marina Maglakelidze, Yee Chao, Erika Garner-Spitzer, Ursula Wiedermann
Purpose:HER2/neu is overexpressed in up to 30% of gastroesophageal adenocarcinomas (GEA) and linked to poor prognosis. Recombinant mAbs to treat HER2/neu-overexpressing cancers are effective with limitations, including resistance and toxicity. Theref
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f60e21e29115932209d40d9524bea17
https://doi.org/10.1158/1078-0432.c.6530562.v1
https://doi.org/10.1158/1078-0432.c.6530562.v1
Autor:
Anthony J. Good, Mark T. Marino, Nicholas J. Ede, Leslie Chong, Christoph C. Zielinski, Joshua Tobias, Mirjana Drinic, Teerapat Ungtrakul, Wen-Chi Chou, Li-Yuan Bai, Aumkhae Sookprasert, Jedzada Maneechavakajorn, Suebpong Tanasanvimon, Thomas Cheung Yau, Chia-Jui Yen, Chaiyut Charoentum, Wichit Arpornwirat, Arunee Dechaphunkul, Iurie Bulat, Marina Maglakelidze, Yee Chao, Erika Garner-Spitzer, Ursula Wiedermann
Supp. Table 1; Supp. Table 2; Supp. Table 3 A,B; Supp. Table 4; Supp. Table 5; Supp. Table 6; Supplementary Data 1; Supplementary Data 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f4b207604681307f928821deb571f02
https://doi.org/10.1158/1078-0432.22480935.v1
https://doi.org/10.1158/1078-0432.22480935.v1
Autor:
Isabel Monroy, Anthony Park, Colin Cook, Guangyan Xiong, Vivien Chan, Cheng Liu, Saul Priceman, Monil Shah, Nimali Withana, Leslie Chong, Yuman Fong
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c71d249ba3a85a26a2eb86768b4427d3
https://doi.org/10.1136/jitc-2022-sitc2022.0368
https://doi.org/10.1136/jitc-2022-sitc2022.0368
Autor:
Anthony Park, Isabel Monroy, Colin Cook, Shuyang He, Kathy Karasiewicz, Monil Shah, Nimali Withana, Leslie Chong, Robert Hariri, Yuman Fong, Saul Priceman
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::59397c6d35155cb99c8950f8bf514101
https://doi.org/10.1136/jitc-2022-sitc2022.0847
https://doi.org/10.1136/jitc-2022-sitc2022.0847
Autor:
Jamie Green Rand, Dave Yamauchi, Shyambabu Chaurasiya, Jianying Zhang, Raju Pillai, Colt Egelston, Jonathan Kessler, Badri Modi, Leslie Chong, Amanda Seiz, Giovanni Selvaggi, Nick Ede, Mireya Murga, Norma Martinez, Wichanee Borisuthirattana, Hans Meisen, Susan Yost, James Waisman, Daphne Stewart, Joanne Mortimer, Yuman Fong, Yuan Yuan
Publikováno v:
Cancer Research. 83:6788-6788
Background: CF33-hNIS-anti-PD-L1 is a novel chimeric orthopoxvirus shown to have anti-cancer activity in triple negative breast cancer (TNBC) xenografts. For clinical tracking of the oncolytic virus (OV), human sodium iodide symporter (hNIS) transgen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d187b0c46001ec7c8154303bc3802964
https://doi.org/10.1158/1538-7445.am2023-6788
https://doi.org/10.1158/1538-7445.am2023-6788
Autor:
Yuan Yuan, Jamie G. Rand, Jianying Zhang, Jonathan Kessler, Badri Modi, Raju Pillai, Colt A. Egelston, Shyambabu Chaurasiya, Mireya Murga, Aileen Tang, Norma Martinez, Hans Meisen, Dave Yamauchi, Susan E. Yost, Leslie Chong, Amanda Seiz, Bonnie Nixon, Nick Ede, James Waisman, Daphne Stewart, Mina S. Sedrak, Yuman Fong
Publikováno v:
Cancer Research. 83:OT3-03
Background: Despite recent FDA approvals of immune checkpoint inhibitor pembrolizumab and drug-antibody conjugate in the treatment of metastatic triple negative breast cancer (mTNBC), the overall survival benefit of these therapies remains modest. On
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ccc4d69cb000a38d8b16c19eaa5da576
https://doi.org/10.1158/1538-7445.sabcs22-ot3-03-01
https://doi.org/10.1158/1538-7445.sabcs22-ot3-03-01
Autor:
Chia Jui Yen, Yee Chao, Wichit Arpornwirat, Joshua Tobias, Marina Maglakelidze, Jedzada Maneechavakajorn, Thomas Yau, Mirjana Drinić, Iurie Bulat, Nicholas J. Ede, Teerapat Ungtrakul, Chaiyut Charoentum, Suebpong Tanasanvimon, Wen-Chi Chou, Aumkhae Sookprasert, Li Yuan Bai, Erika Garner-Spitzer, Arunee Dechaphunkul, Anthony J Good, Leslie Chong, Mark T. Marino, Ursula Wiedermann, Christoph C. Zielinski
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 27(13)
Purpose: HER2/neu is overexpressed in up to 30% of gastroesophageal adenocarcinomas (GEA) and linked to poor prognosis. Recombinant mAbs to treat HER2/neu-overexpressing cancers are effective with limitations, including resistance and toxicity. There
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2688c760672c914e85e12337cdf5605
https://pubmed.ncbi.nlm.nih.gov/33879458
https://pubmed.ncbi.nlm.nih.gov/33879458